SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-21-000017
Filing Date
2021-09-15
Accepted
2021-09-15 15:12:14
Documents
38
Period of Report
2021-07-31

Document Format Files

Seq Description Document Type Size
1 vsbc10qjuly2021.htm   iXBRL 10-Q 345549
2 ex31_1.htm EX-31.1 10932
3 ex31_2.htm EX-31.2 10790
4 ex32_1.htm EX-32.1 4126
5 ex32_2.htm EX-32.2 4048
  Complete submission text file 0001697884-21-000017.txt   1751794

Data Files

Seq Description Document Type Size
6 none-20210731.xsd EX-101.SCH 11226
7 none-20210731_cal.xml EX-101.CAL 13651
8 none-20210731_def.xml EX-101.DEF 17047
9 none-20210731_lab.xml EX-101.LAB 125857
10 none-20210731_pre.xml EX-101.PRE 91006
11 EXTRACTED XBRL INSTANCE DOCUMENT vsbc10qjuly2021_htm.xml XML 193902
Mailing Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 211255240
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services